Article
Preserved T-cell Response in anti-CD20 Treated Multiple Sclerosis Patients Following…
Research square · 2022 · Simon Faissner, author Neele Heitmann, author Ricarda Rohling, author Ulas Ceylan, author Marielena Bongert, author Corinna Marheinecke, author Xiomara Pedreiturria, author Ilya Ayzenberg, author Kerstin Hellwig, author Ingo Schmitz, author Stephanie Pfänder, author Ralf Gold, author
Key facts
| Title | Preserved T-cell Response in anti-CD20 Treated Multiple Sclerosis Patients Following SARS-CoV-2 Vaccination |
|---|---|
| First author | Simon Faissner, author Neele Heitmann, author Ricarda Rohling, author Ulas Ceylan, author Marielena Bongert, author Corinna Marheinecke, author Xiomara Pedreiturria, author Ilya Ayzenberg, author Kerstin Hellwig, author Ingo Schmitz, author Stephanie Pfänder, author Ralf Gold, author |
| Journal | Research square |
| Published | Feb 7, 2022 |
| DOI | 10.21203/rs.3.rs-1109886/v1 |
| Devices mentioned | DEN000008, K022086, K837776 |
| Product codes mentioned | IXJ, NDS, JCI, KIT, NJT |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1